Madrigal Pharmaceuticals, Inc. (MDGL)
USD 291.82
(-7.18%)
USD 291.82
(-7.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -380.49 Million USD | -29.61% |
| 2022 | -293.57 Million USD | -21.07% |
| 2021 | -242.48 Million USD | -17.33% |
| 2020 | -206.67 Million USD | -117.61% |
| 2019 | -94.97 Million USD | -133.45% |
| 2018 | -40.68 Million USD | -26.89% |
| 2017 | -32.06 Million USD | -27.11% |
| 2016 | -25.22 Million USD | 62.69% |
| 2015 | -67.61 Million USD | 19.46% |
| 2014 | -83.95 Million USD | 4.12% |
| 2013 | -87.55 Million USD | -43.68% |
| 2012 | -60.94 Million USD | -34.14% |
| 2011 | -45.43 Million USD | -23.13% |
| 2010 | -36.89 Million USD | -146.53% |
| 2009 | 79.3 Million USD | 184.63% |
| 2008 | -93.7 Million USD | -41.52% |
| 2007 | -66.21 Million USD | -11.94% |
| 2006 | -59.15 Million USD | 16.9% |
| 2005 | -71.18 Million USD | -51.68% |
| 2004 | -46.92 Million USD | -65.86% |
| 2003 | -28.29 Million USD | 21.98% |
| 2002 | -36.26 Million USD | -8943.39% |
| 2001 | -401 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -162.53 Million USD | -6.91% |
| 2024 Q1 | -152.03 Million USD | -29.75% |
| 2024 Q3 | -116.3 Million USD | 28.44% |
| 2023 Q2 | -86.45 Million USD | -10.36% |
| 2023 Q1 | -78.33 Million USD | 8.16% |
| 2023 FY | -380.49 Million USD | -29.61% |
| 2023 Q3 | -98.53 Million USD | -13.98% |
| 2023 Q4 | -117.17 Million USD | -18.92% |
| 2022 FY | -293.57 Million USD | -21.07% |
| 2022 Q2 | -70.27 Million USD | -22.32% |
| 2022 Q1 | -57.44 Million USD | 11.07% |
| 2022 Q4 | -85.29 Million USD | -6.08% |
| 2022 Q3 | -80.41 Million USD | -14.43% |
| 2021 Q2 | -61.74 Million USD | -16.54% |
| 2021 Q1 | -52.97 Million USD | 11.04% |
| 2021 Q3 | -63.16 Million USD | -2.3% |
| 2021 Q4 | -64.6 Million USD | -2.28% |
| 2021 FY | -242.48 Million USD | -17.33% |
| 2020 FY | -206.67 Million USD | -117.61% |
| 2020 Q4 | -59.55 Million USD | -1.31% |
| 2020 Q3 | -58.78 Million USD | -16.81% |
| 2020 Q1 | -38 Million USD | -26.88% |
| 2020 Q2 | -50.32 Million USD | -32.42% |
| 2019 Q3 | -24.19 Million USD | -6.57% |
| 2019 FY | -94.97 Million USD | -133.45% |
| 2019 Q4 | -29.95 Million USD | -23.8% |
| 2019 Q2 | -22.7 Million USD | -25.3% |
| 2019 Q1 | -18.11 Million USD | -25.36% |
| 2018 FY | -40.68 Million USD | -26.89% |
| 2018 Q1 | -7.06 Million USD | 20.67% |
| 2018 Q2 | -7.82 Million USD | -10.71% |
| 2018 Q3 | -11.33 Million USD | -44.81% |
| 2018 Q4 | -14.45 Million USD | -27.54% |
| 2017 FY | -32.06 Million USD | -27.11% |
| 2017 Q3 | -8.63 Million USD | -2.35% |
| 2017 Q2 | -8.43 Million USD | -38.91% |
| 2017 Q1 | -6.07 Million USD | 21.67% |
| 2017 Q4 | -8.91 Million USD | -3.17% |
| 2016 FY | -25.22 Million USD | 62.69% |
| 2016 Q2 | -3.48 Million USD | 45.88% |
| 2016 Q3 | -14.09 Million USD | -303.86% |
| 2016 Q4 | -7.75 Million USD | 44.96% |
| 2016 Q1 | -6.44 Million USD | 37.89% |
| 2015 FY | -67.61 Million USD | 19.46% |
| 2015 Q4 | -10.38 Million USD | 40.32% |
| 2015 Q3 | -17.39 Million USD | 10.82% |
| 2015 Q2 | -19.5 Million USD | 4.07% |
| 2015 Q1 | -20.33 Million USD | -2.2% |
| 2014 Q3 | -19.44 Million USD | 10.38% |
| 2014 Q2 | -21.7 Million USD | 5.26% |
| 2014 FY | -83.95 Million USD | 4.12% |
| 2014 Q1 | -22.9 Million USD | 2.29% |
| 2014 Q4 | -19.89 Million USD | -2.29% |
| 2013 FY | -87.55 Million USD | -43.68% |
| 2013 Q3 | -21.79 Million USD | 1.22% |
| 2013 Q4 | -23.44 Million USD | -7.57% |
| 2013 Q2 | -22.06 Million USD | -8.91% |
| 2013 Q1 | -20.25 Million USD | -14.43% |
| 2012 Q4 | -17.7 Million USD | -21.76% |
| 2012 Q2 | -14.13 Million USD | 2.96% |
| 2012 Q1 | -14.56 Million USD | -42.25% |
| 2012 Q3 | -14.53 Million USD | -2.87% |
| 2012 FY | -60.94 Million USD | -34.14% |
| 2011 Q2 | -12 Million USD | -9.51% |
| 2011 Q1 | -10.96 Million USD | -31.09% |
| 2011 Q3 | -12.21 Million USD | -1.74% |
| 2011 Q4 | -10.23 Million USD | 16.2% |
| 2011 FY | -45.43 Million USD | -23.13% |
| 2010 Q2 | -9.04 Million USD | 2.31% |
| 2010 FY | -36.89 Million USD | -146.53% |
| 2010 Q4 | -8.36 Million USD | 18.24% |
| 2010 Q3 | -10.23 Million USD | -13.12% |
| 2010 Q1 | -9.25 Million USD | -32.64% |
| 2009 Q1 | -23.43 Million USD | 9.39% |
| 2009 Q2 | -8.45 Million USD | 63.93% |
| 2009 Q3 | 118.17 Million USD | 1497.99% |
| 2009 Q4 | -6.98 Million USD | -105.91% |
| 2009 FY | 79.3 Million USD | 184.63% |
| 2008 Q1 | -18.44 Million USD | -12.86% |
| 2008 FY | -93.7 Million USD | -41.52% |
| 2008 Q4 | -25.86 Million USD | 2.22% |
| 2008 Q3 | -26.45 Million USD | -15.27% |
| 2008 Q2 | -22.94 Million USD | -24.41% |
| 2007 Q2 | -17.46 Million USD | -2.67% |
| 2007 Q1 | -17.01 Million USD | -30.81% |
| 2007 FY | -66.21 Million USD | -11.94% |
| 2007 Q3 | -15.39 Million USD | 11.86% |
| 2007 Q4 | -16.34 Million USD | -6.16% |
| 2006 Q2 | -14.92 Million USD | 0.0% |
| 2006 Q4 | -13 Million USD | 15.45% |
| 2006 Q1 | -14.92 Million USD | 3.64% |
| 2006 FY | -59.15 Million USD | 16.9% |
| 2006 Q3 | -15.38 Million USD | -3.04% |
| 2005 Q3 | -26.68 Million USD | 0.0% |
| 2005 Q4 | -15.49 Million USD | 41.95% |
| 2005 Q2 | -26.68 Million USD | -44.26% |
| 2005 FY | -71.18 Million USD | -51.68% |
| 2005 Q1 | -18.49 Million USD | 0.0% |
| 2004 FY | -46.92 Million USD | -65.86% |
| 2004 Q1 | -8.96 Million USD | 0.0% |
| 2003 FY | -28.29 Million USD | 21.98% |
| 2002 FY | -36.26 Million USD | -8943.39% |
| 2001 FY | -401 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -60.407% |
| Alkermes plc | 414.12 Million USD | 191.88% |
| Agenus Inc. | -159.54 Million USD | -138.482% |
| Aptorum Group Limited | -10.52 Million USD | -3515.738% |
| Ardelyx, Inc. | -63.27 Million USD | -501.328% |
| Dyadic International, Inc. | -8.22 Million USD | -4523.427% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -31820.805% |
| Lantern Pharma Inc. | -17.87 Million USD | -2028.343% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -1793.977% |
| Novavax, Inc. | -566.51 Million USD | 32.835% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -421.377% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -362.913% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -1859.449% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -3502.158% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -616.209% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1465.401% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -904.769% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -194.986% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -353.436% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2069.428% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -764.567% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1431.541% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -173.677% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -34.844% |
| AlloVir, Inc. | -181.33 Million USD | -109.835% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -85.606% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1200.485% |
| Bicycle Therapeutics plc | -189.94 Million USD | -100.318% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -121.499% |
| ChromaDex Corporation | -5.59 Million USD | -6695.785% |
| Chimerix, Inc. | -93.06 Million USD | -308.85% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -744.097% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -227.847% |
| CRISPR Therapeutics AG | -222.53 Million USD | -70.98% |
| Precision BioSciences, Inc. | -43.73 Million USD | -769.984% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -99.724% |
| Fortress Biotech, Inc. | -142.34 Million USD | -167.311% |
| Fortress Biotech, Inc. | -142.34 Million USD | -167.311% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -289.477% |
| ImmuCell Corporation | -5.74 Million USD | -6519.534% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -183.046% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2257.31% |
| Incyte Corporation | 620.52 Million USD | 161.318% |
| Innoviva, Inc. | 176.7 Million USD | 315.323% |
| IO Biotech, Inc. | -91.44 Million USD | -316.102% |
| Jaguar Health, Inc. | -34.29 Million USD | -1009.609% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -123.899% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 3286.2% |
| ContextLogic Inc. | -328 Million USD | -16.005% |
| MiMedx Group, Inc. | 37.11 Million USD | 1125.154% |
| MEI Pharma, Inc. | 14.54 Million USD | 2716.531% |
| NextCure, Inc. | -67.63 Million USD | -462.556% |
| Onconetix, Inc. | -36.03 Million USD | -955.919% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -812.154% |
| Opthea Limited | -191.84 Million USD | -98.337% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -13727.042% |
| Vaxcyte, Inc. | -468.04 Million USD | 18.705% |
| PDS Biotechnology Corporation | -43.04 Million USD | -783.945% |
| Precigen, Inc. | -88.92 Million USD | -327.894% |
| Pharming Group N.V. | -4.87 Million USD | -7697.778% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -127.417% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1178.72% |
| PureTech Health plc | -146.19 Million USD | -160.259% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -1756.893% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -61.502% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1465.401% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -38.865% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1198.4% |
| Acelyrin, Inc. | -422.06 Million USD | 9.849% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -2950638.817% |
| Summit Therapeutics Inc. | -89.73 Million USD | -324.017% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -926.592% |
| Senti Biosciences, Inc. | -92.72 Million USD | -310.34% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -231.52% |
| Elevation Oncology, Inc. | -45.44 Million USD | -737.267% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1010.386% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -9552.242% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -11933.397% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1052.285% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -4375.897% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -459.586% |
| Seer, Inc. | -103.46 Million USD | -267.76% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -478.622% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -428.959% |
| ESSA Pharma Inc. | -32.13 Million USD | -1084.088% |
| GlycoMimetics, Inc. | -39.27 Million USD | -868.792% |
| GT Biopharma, Inc. | -13.57 Million USD | -2702.711% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -73.567% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -722.587% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 538.299% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -570.371% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -638.741% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -3728.835% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 24.552% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -5416.034% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -650.589% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -46.537% |
| Aptose Biosciences Inc. | -52.35 Million USD | -626.748% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -2538.527% |
| Soligenix, Inc. | -7.69 Million USD | -4842.829% |
| Century Therapeutics, Inc. | -146.54 Million USD | -159.643% |
| Kura Oncology, Inc. | -165.8 Million USD | -129.485% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -307.13% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -4473.819% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -15232.448% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -5768.229% |
| Autolus Therapeutics plc | -195.02 Million USD | -95.098% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -349.456% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -416.543% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -1700.312% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -67.594% |
| GRI Bio, Inc. | -11.38 Million USD | -3241.495% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -8326.041% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -190.028% |
| IGM Biosciences, Inc. | -263.46 Million USD | -44.422% |
| INmune Bio, Inc. | -29.74 Million USD | -1179.365% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -243.982% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -899.324% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2281.172% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2312.657% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -522.763% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -253.877% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -37.858% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -87.253% |
| Verastem, Inc. | -92.08 Million USD | -313.205% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -707.247% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -106.628% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -221.419% |
| Histogen Inc. | -10.64 Million USD | -3475.082% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -2359.262% |
| Surrozen, Inc. | -45.78 Million USD | -731.14% |
| Organovo Holdings, Inc. | -15.08 Million USD | -2422.18% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -7375.017% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -541.846% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -641.794% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1405.127% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -4884.984% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -122.145% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -685.371% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -386.537% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -2399.847% |
| Apollomics, Inc. | -54.83 Million USD | -593.905% |
| Amarin Corporation plc | -67.58 Million USD | -462.964% |
| Mesoblast Limited | -58.79 Million USD | -547.168% |
| Turnstone Biologics Corp. | -59.03 Million USD | -544.559% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -129.865% |
| Synaptogenix, Inc. | -8.31 Million USD | -4476.65% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -2508.638% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -314.976% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7841.119% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -4208.525% |
| Exelixis, Inc. | 170.88 Million USD | 322.662% |
| Better Therapeutics, Inc. | -38.26 Million USD | -894.449% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -145.382% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 26.42% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3122.613% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -4631.416% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1168.616% |
| Gritstone bio, Inc. | -154.63 Million USD | -146.062% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -452.557% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2122.127% |
| Avid Bioservices, Inc. | -18.67 Million USD | -1937.135% |
| Insmed Incorporated | -709.62 Million USD | 46.381% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -2325.119% |
| MediWound Ltd. | -15.29 Million USD | -2388.528% |
| OmniAb, Inc. | -69.41 Million USD | -448.115% |
| Alector, Inc. | -151.74 Million USD | -150.755% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -252.367% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -629.646% |
| Zai Lab Limited | -366.57 Million USD | -3.798% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -20.115% |
| Aura Biosciences, Inc. | -84.99 Million USD | -347.69% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -54.989% |
| Immunic, Inc. | -99.22 Million USD | -283.476% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -165.787% |
| Veracyte, Inc. | -85.79 Million USD | -343.494% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -35.016% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2577.664% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -5424.084% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -1924.71% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 165.764% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1394.896% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1080.609% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1944.114% |
| Galecto, Inc. | -39.9 Million USD | -853.505% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -804.349% |
| Fortrea Holdings Inc. | 63.1 Million USD | 703.005% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -170.922% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1217.598% |
| XBiotech Inc. | -37.51 Million USD | -914.385% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -452.557% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -466.889% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -252.618% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1382.144% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -613.983% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 33.153% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -384.758% |
| Vaxxinity, Inc. | -58.28 Million USD | -552.82% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -266.888% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1609.854% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -340.307% |
| NexImmune, Inc. | -29.19 Million USD | -1203.404% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -6670.232% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -2509.465% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 109.402% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1394.544% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3147.973% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -199.457% |
| Ainos, Inc. | -13.2 Million USD | -2781.149% |
| Pluri Inc. | -22.15 Million USD | -1617.195% |
| Prothena Corporation plc | -191.03 Million USD | -99.175% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -175.646% |
| Celularity Inc. | -192.28 Million USD | -97.879% |
| Rallybio Corporation | -78.93 Million USD | -382.055% |
| Cue Biopharma, Inc. | -52.14 Million USD | -629.632% |
| MeiraGTx Holdings plc | -137.06 Million USD | -177.611% |
| Omeros Corporation | -164.53 Million USD | -131.262% |
| Humacyte, Inc. | -100.04 Million USD | -280.317% |
| Immunocore Holdings plc | -59.64 Million USD | -537.892% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -1950.197% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1454.123% |
| Blueprint Medicines Corporation | -486.27 Million USD | 21.753% |
| CalciMedica, Inc. | -21.87 Million USD | -1639.41% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -409.638% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -189.384% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -122.129% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -16.395% |
| Pulmatrix, Inc. | -14.74 Million USD | -2481.384% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -964.473% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -328.168% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 26.159% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -463.272% |
| Cytokinetics, Incorporated | -496.2 Million USD | 23.319% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1005.482% |
| Nutriband Inc. | -4.87 Million USD | -7709.971% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -772.437% |
| Vor Biopharma Inc. | -126.03 Million USD | -201.895% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 108.97% |
| Evogene Ltd. | -26.39 Million USD | -1341.764% |
| ProKidney Corp. | -151.52 Million USD | -151.116% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -489.596% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -4846.49% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 37.354% |
| CorMedix Inc. | -48.95 Million USD | -677.192% |
| BioLineRx Ltd. | -49.69 Million USD | -665.678% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -233.263% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -899.412% |
| Atai Life Sciences N.V. | -125.47 Million USD | -203.254% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -366.07% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -367.388% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -52.817% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1137.788% |
| MediciNova, Inc. | -9.9 Million USD | -3743.291% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -201.09% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -5153.685% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1322.791% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -64.131% |
| Biomea Fusion, Inc. | -126.13 Million USD | -201.658% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -8.899% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1239.02% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -99.12% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -65.466% |
| Absci Corporation | -115.51 Million USD | -229.391% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1279.258% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -237.119% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -57.125% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1410.144% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -82.936% |
| Allakos Inc. | -196.05 Million USD | -94.075% |
| Imunon, Inc. | -21.03 Million USD | -1709.264% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -243.83% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 454.669% |
| BioAtla, Inc. | -129.68 Million USD | -193.396% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3122.613% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -2301.666% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -16.098% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -811.193% |
| XOMA Corporation | -41.84 Million USD | -809.233% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -261.561% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -213.178% |
| aTyr Pharma, Inc. | -54.91 Million USD | -592.831% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -335.216% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -120.105% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -49.537% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1672.552% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -4532.989% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2164.049% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -4302678.573% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 212.715% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5723.305% |
| UroGen Pharma Ltd. | -65.53 Million USD | -480.591% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -326.192% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -5138.818% |
| Orgenesis Inc. | -53.63 Million USD | -609.404% |
| Entera Bio Ltd. | -8.89 Million USD | -4179.564% |
| GH Research PLC | -41.22 Million USD | -823.041% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1380.068% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -358.136% |
| Xencor, Inc. | -138.63 Million USD | -174.451% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -7281.703% |
| Replimune Group, Inc. | -234.77 Million USD | -62.07% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1670.48% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -2627.179% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5723.305% |
| Portage Biotech Inc. | -18.25 Million USD | -1984.567% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -5153.685% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -262.512% |
| OncoCyte Corporation | -25.13 Million USD | -1413.749% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3265.775% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3221.061% |
| Purple Biotech Ltd. | 22.27 Million USD | 1808.482% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -4965.176% |
| scPharmaceuticals Inc. | -55.39 Million USD | -586.865% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -1913.452% |
| HilleVax, Inc. | -133.34 Million USD | -185.347% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -3057.905% |
| Tharimmune, Inc. | -9.45 Million USD | -3924.19% |
| Genprex, Inc. | -31.07 Million USD | -1124.422% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -102.183% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1112.659% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -49638.039% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -6885.527% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2415789.034% |
| Savara Inc. | -60 Million USD | -534.086% |
| Curis, Inc. | -48.33 Million USD | -687.255% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1133.779% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -7192.996% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -5128.748% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1296.316% |
| BeiGene, Ltd. | -1.2 Billion USD | 68.495% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -1808.272% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 21.899% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -306.287% |
| Erasca, Inc. | -141.52 Million USD | -168.854% |
| bluebird bio, Inc. | -244.26 Million USD | -55.774% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -8305.085% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 295.687% |
| DBV Technologies S.A. | -76.43 Million USD | -397.823% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -8305.085% |
| Moderna, Inc. | -4.23 Billion USD | 91.024% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -792.994% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -5882.642% |
| Molecular Templates, Inc. | -10.46 Million USD | -3535.544% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -465.903% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -0.996% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -165.504% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -631.822% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -146.209% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -82.817% |
| MacroGenics, Inc. | -168.24 Million USD | -126.157% |
| RenovoRx, Inc. | -11.39 Million USD | -3238.856% |
| Adicet Bio, Inc. | -152.03 Million USD | -150.264% |
| Prime Medicine, Inc. | -191.29 Million USD | -98.908% |
| Aditxt, Inc. | -26.06 Million USD | -1359.941% |
| Adagene Inc. | -23.71 Million USD | -1504.124% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5105.074% |
| Quantum-Si incorporated | -111.17 Million USD | -242.262% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1102.275% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2510.112% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 411.846% |
| SciSparc Ltd. | -5.77 Million USD | -6490.958% |
| Vericel Corporation | -6.46 Million USD | -5786.386% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -4295.411% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1545.774% |
| Generation Bio Co. | -138.56 Million USD | -174.601% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -358.263% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -340.083% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -57.816% |
| Invivyd, Inc. | -207.78 Million USD | -83.122% |
| Relay Therapeutics, Inc. | -373 Million USD | -2.01% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -3957.108% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1871.314% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3598.804% |
| 2seventy bio, Inc. | -216.7 Million USD | -75.584% |
| ADMA Biologics, Inc. | 21.63 Million USD | 1858.95% |
| Clene Inc. | -40.54 Million USD | -838.569% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1480.273% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -594.386% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1322.791% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -8.695% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -935.87% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 2466.71% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -266.913% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1019.04% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -123.456% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 44.397% |
| Evaxion Biotech A/S | -22.19 Million USD | -1614.178% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -361.868% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -70.531% |
| Trevena, Inc. | -35.28 Million USD | -978.259% |
| Surrozen, Inc. | -45.78 Million USD | -731.14% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -375.947% |
| Cingulate Inc. | -22.75 Million USD | -1571.835% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 5178.697% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -751.85% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -4521.068% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -271.006% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -418.535% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -512.972% |
| Clearmind Medicine Inc. | -8.74 Million USD | -4252.829% |
| Kronos Bio, Inc. | -121.83 Million USD | -212.317% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -399.365% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -12872.995% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -277.375% |
| Statera Biopharma, Inc. | -98.34 Million USD | -286.904% |
| ImmunityBio, Inc. | -362.25 Million USD | -5.037% |
| Korro Bio, Inc. | -84.53 Million USD | -350.11% |
| Kineta, Inc. | -15.72 Million USD | -2319.996% |
| BioVie Inc. | -32.17 Million USD | -1082.414% |
| Codexis, Inc. | -68.06 Million USD | -458.986% |
| Celularity Inc. | -192.28 Million USD | -97.879% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -70.926% |
| Celcuity Inc. | -66.23 Million USD | -474.504% |
| Virax Biolabs Group Limited | -6.49 Million USD | -5756.963% |
| Cibus, Inc. | -318.88 Million USD | -19.322% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -784.874% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1024.264% |
| IN8bio, Inc. | -30.33 Million USD | -1154.231% |
| Kodiak Sciences Inc. | -277.32 Million USD | -37.204% |
| Annexon, Inc. | -143.72 Million USD | -164.743% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -207.37% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -488.584% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1522.999% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -7.567% |
| Eyenovia, Inc. | -25.4 Million USD | -1397.636% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1265.735% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6740.992% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -380.831% |
| Arcellx, Inc. | -89.88 Million USD | -323.338% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -737.875% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -177.315% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1123.106% |
| Moolec Science SA | -6.65 Million USD | -5618.472% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -522.356% |
| Geron Corporation | -193.94 Million USD | -96.189% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -779.699% |
| Royalty Pharma plc | 1.49 Billion USD | 125.5% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -131.781% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3979.132% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1637.848% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -122.568% |
| Humacyte, Inc. | -100.04 Million USD | -280.317% |
| Structure Therapeutics Inc. | -102.77 Million USD | -270.222% |
| 89bio, Inc. | -151.2 Million USD | -151.644% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -374.837% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -2516.891% |
| Genelux Corporation | -24.16 Million USD | -1474.575% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1021.646% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -121.541% |
| Notable Labs, Ltd. | -14.65 Million USD | -2496.002% |
| Liquidia Corporation | -73.38 Million USD | -418.5% |
| Mustang Bio, Inc. | -50.72 Million USD | -650.101% |
| Immunovant, Inc. | -282.7 Million USD | -34.589% |
| Quantum-Si incorporated | -111.17 Million USD | -242.262% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -387.172% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1689.138% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -272.991% |
| Acasti Pharma Inc. | -11.31 Million USD | -3263.649% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1560.025% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2281.172% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -77.757% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -10270.361% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2295.166% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1204.99% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -819.428% |
| PepGen Inc. | -84.76 Million USD | -348.878% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1184.115% |
| United Therapeutics Corporation | 1.18 Billion USD | 132.112% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1561.772% |
| Solid Biosciences Inc. | -104.31 Million USD | -264.757% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1059.762% |
| Immuneering Corporation | -58.41 Million USD | -551.391% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -7375.017% |
| Silo Pharma, Inc. | -3.85 Million USD | -9768.679% |
| Belite Bio, Inc | -31.66 Million USD | -1101.516% |
| XOMA Corporation | -41.84 Million USD | -809.233% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -463.531% |
| Bionomics Limited | -17.89 Billion USD | 97.873% |
| Apogee Therapeutics, Inc. | -93 Million USD | -309.122% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1166.413% |
| uniQure N.V. | -282.87 Million USD | -34.512% |
| Cassava Sciences, Inc. | -105.95 Million USD | -259.104% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5105.074% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -193.81% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1071.262% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -4479.459% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1194.424% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6740.992% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2577.664% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -4180.526% |
| Altimmune, Inc. | -95.92 Million USD | -296.643% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -417.724% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1166.413% |
| Compugen Ltd. | -12.99 Million USD | -2828.695% |
| Peak Bio, Inc. | -1356.23 USD | -28055318.329% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -667.067% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1591.845% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -57.033% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1179.15% |
| Zura Bio Limited | -62.63 Million USD | -507.452% |
| PolyPid Ltd. | -22.86 Million USD | -1563.952% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2237.773% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1179.15% |
| Instil Bio, Inc. | -159.16 Million USD | -139.052% |
| argenx SE | -425.04 Million USD | 10.482% |
| Immunome, Inc. | -109.53 Million USD | -247.39% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -655.507% |
| Verona Pharma plc | -67.83 Million USD | -460.948% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1360.077% |
| Shattuck Labs, Inc. | -91.95 Million USD | -313.776% |
| CervoMed Inc. | -7.81 Million USD | -4770.103% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -420.443% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -2756.362% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -689.837% |
| Moolec Science SA | -6.65 Million USD | -5618.472% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2213.265% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -181.376% |
| AnaptysBio, Inc. | -164.41 Million USD | -131.43% |
| Design Therapeutics, Inc. | -78.19 Million USD | -386.63% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -337.146% |
| NeurAxis, Inc. | -6.66 Million USD | -5609.3% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -839.519% |
| Lumos Pharma, Inc. | -36.61 Million USD | -939.209% |
| Achilles Therapeutics plc | -75.25 Million USD | -405.609% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1360.077% |
| 180 Life Sciences Corp. | -13.47 Million USD | -2723.194% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 7479.229% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -12872.995% |
| Nutriband Inc. | -4.87 Million USD | -7709.971% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -243.47% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -586.209% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -648.477% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -475.646% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -603.02% |
| Palisade Bio, Inc. | -13.07 Million USD | -2811.217% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -737.931% |
| Beam Therapeutics Inc. | -176.48 Million USD | -115.597% |
| Neurogene Inc. | -55.58 Million USD | -584.555% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -248.586% |
| AEON Biopharma, Inc. | -48.42 Million USD | -685.678% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -293.44% |
| Sesen Bio, Inc. | -25.9 Million USD | -1368.586% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -355.526% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -2922.953% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 17.384% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -425.264% |
| Athira Pharma, Inc. | -125.46 Million USD | -203.266% |
| Vaccinex, Inc. | -22.88 Million USD | -1562.644% |
| HCW Biologics Inc. | -25.71 Million USD | -1379.541% |
| XOMA Corporation | -41.84 Million USD | -809.233% |
| Nektar Therapeutics | -137.42 Million USD | -176.875% |
| Arvinas, Inc. | -401.5 Million USD | 5.231% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -4302678.573% |
| Merus N.V. | -156.54 Million USD | -143.055% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -279.505% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -999.064% |
| Rezolute, Inc. | -70.42 Million USD | -440.301% |
| Clene Inc. | -40.54 Million USD | -838.569% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2223.147% |
| BeyondSpring Inc. | -23.11 Million USD | -1546.171% |
| Synlogic, Inc. | -55.16 Million USD | -589.792% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2022.238% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3415.299% |
| Peak Bio, Inc. | -1356.23 USD | -28055318.329% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -839.427% |
| Krystal Biotech, Inc. | -109.72 Million USD | -246.766% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -193.729% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -10.928% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -7917.273% |
| MannKind Corporation | 8.67 Million USD | 4484.605% |
| Ikena Oncology, Inc. | -75.41 Million USD | -404.523% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -3844.19% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -465.962% |
| Gossamer Bio, Inc. | -183.75 Million USD | -107.063% |
| CohBar, Inc. | -12.38 Million USD | -2971.415% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -650.13% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1279.258% |
| Legend Biotech Corporation | -439.48 Million USD | 13.422% |
| Mural Oncology plc | -194.63 Million USD | -95.489% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -466.695% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2256.703% |
| Disc Medicine, Inc. | -91.12 Million USD | -317.554% |
| Champions Oncology, Inc. | -7.35 Million USD | -5072.594% |
| REGENXBIO Inc. | -268.12 Million USD | -41.908% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3450.003% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -582.431% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -876.616% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -232.726% |
| Vaxart, Inc. | -83.34 Million USD | -356.52% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -4365.911% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -789.132% |
| Cellectis S.A. | -106.62 Million USD | -256.851% |
| Longeveron Inc. | -21.02 Million USD | -1709.387% |
| Repare Therapeutics Inc. | -116.22 Million USD | -227.382% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -42.069% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -403.002% |
| Revolution Medicines, Inc. | -487.18 Million USD | 21.899% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -5620.024% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -765.669% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -410.117% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -446.415% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -3355.599% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 108.833% |
| Denali Therapeutics Inc. | -196.69 Million USD | -93.441% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -4295.411% |
| Veru Inc. | -93.78 Million USD | -305.723% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1531.0% |
| Cingulate Inc. | -22.75 Million USD | -1571.835% |
| Passage Bio, Inc. | -108.38 Million USD | -251.047% |
| Context Therapeutics Inc. | -25.07 Million USD | -1417.576% |
| Exicure, Inc. | -14.99 Million USD | -2437.317% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -84.649% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -837.228% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -3815.802% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -106.391% |
| Nuvalent, Inc. | -149.49 Million USD | -154.526% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -4530.872% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -328.82% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -1731.597% |
| OmniAb, Inc. | -69.41 Million USD | -448.115% |
| Anew Medical, Inc. | -1.3 Million USD | -29150.023% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -2879.375% |
| Lipocine Inc. | -17.93 Million USD | -2022.006% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -455.363% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -399.653% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -899.324% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -862.623% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1599.857% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 34.38% |
| Ocugen, Inc. | -65.53 Million USD | -480.635% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -305.361% |
| Q32 Bio Inc. | -92.1 Million USD | -313.125% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1674.784% |
| Alumis Inc. Common Stock | -158.17 Million USD | -140.555% |
| Equillium, Inc. | -14.52 Million USD | -2520.135% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -509.711% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4714.364% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1916.93% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -710.411% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -250.797% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -3078.743% |
| Dominari Holdings Inc. | -21.79 Million USD | -1645.715% |
| Edesa Biotech, Inc. | -9.22 Million USD | -4025.621% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1392.024% |
| Bio-Techne Corporation | 206.68 Million USD | 284.094% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 2.808% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 298.144% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -187.651% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -891.107% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -151.816% |
| Nkarta, Inc. | -131.65 Million USD | -189.021% |
| BioCardia, Inc. | -11.64 Million USD | -3167.743% |
| Iterum Therapeutics plc | -47.46 Million USD | -701.584% |